[You may also click here for additional information] NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against V.F. Corporation ("VFC†or the "Company†) (NYSE: VFC). From a closing market price of $14.43 per share on May 20, 2025, VFC's stock price fell to $12.15 per share on May 21, 2025, a decline of about 15.8% in the span of just a single day. SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Viola ...

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against PetMed Express, Inc. for possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The investigation is focused on whether PetMed has engaged in any unlawful activities that may have affected its stockholders [1][2] - Investors who have suffered losses and are long-term stockholders are encouraged to reach out for more information regarding their rights [3] Company Background - Bragar Eagel & Squire, P.C. is a law firm that represents individual and institutional investors in various types of litigation across the United States [4] - The firm has offices in New York and California and specializes in commercial and securities litigation [4] Recent Developments - On June 10, 2025, PetMed announced a delay in releasing its fourth quarter and fiscal year 2025 earnings due to the need for additional time to complete the year-end audit [6] - Following this announcement, PetMed's stock price dropped by $0.47, or 11.22%, closing at $3.72 per share on June 11, 2025 [6]

Core Insights - Bragar Eagel & Squire, P.C. is investigating potential claims against Synopsys, Inc. regarding possible violations of federal securities laws and unlawful business practices [1][2] Investigation Details - The investigation is focused on whether Synopsys has engaged in any unlawful activities that may have affected stockholders [2] Financial Performance - On September 9, 2025, Synopsys reported its Q3 2025 financial results, indicating that its IP business underperformed expectations [6] - The CEO mentioned a more conservative outlook for Q4 while guiding for another year of profitable growth [6] - Following the announcement, Baird downgraded Synopsys's rating from Outperform to Neutral and reduced its price target from $670 to $535 [6] - As a result of this news, Synopsys's stock price dropped by $216.59, or 35.84%, closing at $387.78 per share on September 10, 2025 [6]